Acesso livre
Acesso livre

Saúde Pública em Pediatria

Opinião | Dados sobre a testagem rotineira para Covid pode ajudar as escolas a permanecerem abertas este ano.

1 Out, 2021 | 19:27h

Data from routine Covid testing can help schools stay open this year – STAT

Conteúdo relacionado: Cluster RCT: Daily contact testing of school-based contacts was non-inferior to self-isolation for control of COVID-19 transmission.

OMS e parceiros chamam para uma ação urgente contra a meningite – Novas estratégias contra a meningite visam a salvar mais de 200.000 vidas anualmente.

1 Out, 2021 | 19:17h

Comunicado de imprensa: WHO and partners call for urgent action on meningitis – New meningitis strategy aims to save more than 200,000 lives annually – World Health Organization

Ver diretriz: Defeating meningitis by 2030: a global road map – World Health Organization

Comentários:

WHO Launches First Global Strategy to Eliminate Bacterial Meningitis by 2030 – Health Policy Watch

LSHTM joins WHO to call for urgent action on meningitis – London School of Hygiene & Tropical Medicine

 

Comentário no Twitter (fio – clique para saber mais)

 

Editorial | É hora de mandar as crianças de volta para a escola.

1 Out, 2021 | 18:49h

It’s time to send children back to school – Nature Medicine

Relatório do CDC | Escolas que não exigiram o uso de máscaras ficaram mais propensas a vivenciar surtos de Covid-19.

27 Set, 2021 | 13:26h

Association Between K–12 School Mask Policies and School-Associated COVID-19 Outbreaks — Maricopa and Pima Counties, Arizona, July–August 2021 – CDC Morbidity and Mortality Weekly Report

Comentário: Schools Without Mask Requirements More Likely to See COVID-19 Outbreaks – U.S. News

 

Comentário no Twitter

 

Estudo randomizado de fase 1/2 | Segurança e imunogenicidade de vacina inativada contra COVID-19 (BBIBP-CorV) em crianças e adolescentes de 3 a 17 anos de idade.

27 Set, 2021 | 12:11h

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial – The Lancet Infectious Diseases

Conteúdo relacionado: Phase 1/2 RCT: CoronaVac is well tolerated and safe and induces strong humoral responses in children and adolescents aged 3–17 years.

[Comunicado de imprensa – ainda não publicado] Pfizer anuncia que sua vacina contra COVID-19 produz forte resposta imune em crianças de 5 a 11 anos.

27 Set, 2021 | 11:00h

Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years – Pfizer and BioNTech

Comentários:

Covid-19 vaccine for 5- to 11-year-olds is safe and shows ‘robust’ antibody response, Pfizer says – CNN

Pfizer says COVID-19 vaccine safe, effective in younger children – CIDRAP

Pfizer Covid-19 vaccine generates robust antibody response in children, without serious safety issues, company says – STAT

Expert reaction to press release giving topline results from Pfizer and BioNTech from their phase 2/3 trial looking at safety and antibody responses from their COVID-19 vaccine in children aged 5 to 11 – Science Media Centre

 

Comentários no Twitter

(fio – clique para saber mais)

(fio – clique para saber mais)

 

Atualização de 2019 sobre COVID-19 e gestação.

27 Set, 2021 | 10:54h

An Update on Coronavirus Disease 2019 (COVID-19) and Pregnancy – American Journal of Obstetrics and Gynecology

Revisão | Sintomas de “long COVID” em crianças raramente persistem por mais de 3 meses.

20 Set, 2021 | 13:57h

Comunicado de imprensa: Long COVID symptoms in children rarely persist beyond three months –  Murdoch Children’s Research Institute

Estudo original: How Common Is Long COVID in Children and Adolescents? – The Pediatric Infectious Disease Journal

Comentário: Long Covid in children and adolescents is less common than previously feared – The Guardian

Conteúdos relacionados:

Cohort study: long term follow-up showed most patients with post–COVID-19 Multisystem Inflammatory Syndrome in Children had good outcomes with no significant medium- or long-term sequelae.

Long COVID: the physical and mental health of children and non-hospitalized young people after SARS-CoV-2 infection – one in seven children may still have symptoms 15 weeks after infection.

Do kids get long COVID? And how often? A pediatrician looks at the data – Children also get Long Covid, but much less often than adults.

Illness duration and symptom profile in symptomatic school-aged children tested for SARS-CoV-2 – “Only 25 (1.8%) of 1379 children experienced symptoms for at least 56 days.”

Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents – “This study found a low prevalence of symptoms compatible with long COVID in a randomly selected cohort of children assessed 6 months after serologic testing”.

Study shows low incidence of post-acute COVID-19 symptoms (“Long Covid”) in children after mild disease

Cohort study: Risk factors for long covid in previously hospitalized children.

M-A: More than 50 long-term effects of COVID-19.

 

Comentário no Twitter (fio – clique para saber mais)

 

Estudo randomizado | A adição da telemedicina visando ao aprimoramento do cuidado padrão de doenças pediátricas complexas foi associada com melhora nos desfechos clínicos e na redução de custos.

17 Set, 2021 | 12:56h

Telemedicine for Children With Medical Complexity: A Randomized Clinical Trial – Pediatrics

Revisão | Prevenção de lesões não intencionais em crianças menores de 5 anos de idade.

17 Set, 2021 | 12:54h

Prevention of unintentional injuries in children under five years – BMC Pediatrics

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.